Results 11 to 20 of about 5,157,057 (389)

Thyroid cancer, recent advances in diagnosis and therapy

International Journal of Cancer, 2021
Over the past several decades, the approach to the diagnosis and management of patients with follicular cell‐derived thyroid cancer has evolved based on improved classification of patients better matching clinical outcomes, as well as advances in imaging,
F. Nabhan, Priya H. Dedhia, M. Ringel
semanticscholar   +1 more source

Aggressiveness of Differentiated Thyroid Carcinoma in Pediatric Patients Younger Than 16 years: A Propensity Score-Matched Analysis

Frontiers in Oncology, 2022
BackgroundThe biological behavior of thyroid cancer in children has been known to be different from that in adults. We sought to understand the differences between DTC presentation in pediatric (<16 years) and adult patients, to guide better prognosis
Soo Young Kim, Hyeok Jun Yun, Hojin Chang, Seok-Mo Kim, Soyoung Jeon, Sujee Lee, Yong Sang Lee, Hang-Seok Chang, Cheong Soo Park   +8 more
doaj   +1 more source

Fine Needle Biopsy Versus Core Needle Biopsy Combined With/Without Thyroglobulin or BRAF 600E Mutation Assessment for Detecting Cervical Nodal Metastasis of Papillary Thyroid Carcinoma

Frontiers in Endocrinology, 2021
ObjectivesTo analyze the diagnostic benefit of fine needle aspiration biopsy cytology (FNAB-C) and core needle biopsy tissue (CNB-T) with the addition of thyroglobulin (Tg) in the washout of the needle or BRAF V600E mutation assessment in assessing ...
Xiaojun Zhang, Xu Zhang, Wei Du, Liyuan Dai, Ruihua Luo, Qigen Fang, Hong Ge   +6 more
doaj   +1 more source

Feasibility of Apatinib in Radioiodine-Refractory Differentiated Thyroid Carcinoma

Frontiers in Endocrinology, 2022
ObjectivesOur aim was to describe our experience in using apatinib as treatment for radioiodine-refractory differentiated thyroid carcinoma (RAIR-DTC).MethodsForty-seven patients undergoing apatinib treatment for RAIR-DTC were prospectively enrolled in ...
Wei Du, Xiangyu Shi, Qigen Fang, Xu Zhang, Shanting Liu   +4 more
doaj   +1 more source

Associations between artificial light at night and risk for thyroid cancer: A large US cohort study

Cancer, 2021
Light at night (LAN) inhibits nighttime secretion of melatonin and may cause circadian disruption, which may be a risk factor for cancer. Recent studies have linked high LAN exposure with elevated breast cancer risk.
Dong Zhang, Rena R. Jones, Peter James, C. Kitahara, Q. Xiao   +4 more
semanticscholar   +1 more source

Update on Fundamental Mechanisms of Thyroid Cancer

Frontiers in Endocrinology, 2020
The incidence of thyroid cancer (TC) has increased worldwide over the past four decades. TC is divided into three main histological types: differentiated (papillary and follicular TC), undifferentiated (poorly differentiated and anaplastic TC), and ...
A. Prete, Patricia Borges de Souza, S. Censi, M. Muzza, Nicole Nucci, M. Sponziello   +5 more
semanticscholar   +1 more source

Impact of submandibular gland preservation in neck management of early-stage buccal squamous cell carcinoma on locoregional control and disease-specific survival

BMC Cancer, 2020
Background The feasibility of submandibular gland (SMG) preservation in oral squamous cell carcinoma (SCC) has occasionally been analyzed, but the differences in survival associated with the presence or absence of SMG preservation remain unknown.
Bo Gu, Qigen Fang, Yao Wu, Wei Du, Xu Zhang, Defeng Chen   +5 more
doaj   +1 more source

The potential value of LC-MS non-targeted metabonomics in the diagnosis of follicular thyroid carcinoma

Frontiers in Oncology, 2022
BackgroundTo explore the metabolic differences of follicular thyroid carcinoma (FTC) by metabonomics, to find potential biomarkers for the diagnosis of FTC, and to explore the pathogenesis and diagnosis and treatment strategies of FTC.MethodThe ...
Jiali Qin, Yang Yang, Wei Du, Wei Du, Gang Li, Yao Wu, Ruihua Luo, Shanting Liu, Jie Fan   +8 more
doaj   +1 more source

Characterizing dedifferentiation of thyroid cancer by integrated analysis

Science Advances, 2021
Clinical staining and targeting CREB3L1 facilitates precise stratification and a potential treatment strategy for thyroid cancer. Understanding of dedifferentiation, an indicator of poo prognosis for patients with thyroid cancer, has been hampered by ...
Han Luo, Xuyang Xia, G. Kim, Yang Liu, Zhinan Xue, Lingyun Zhang, Y. Shu, Tian Yang, Yan Chen, Shouyue Zhang, Haining Chen, Weihan Zhang, Ruicen Li, Huairong Tang, B. Dong, Xianghui Fu, Wei Cheng, Wei Zhang, Li Yang, Yong Peng, Lunzhi Dai, Hongbo Hu, Yong Jiang, C. Gong, Yiguo Hu, Jingqiang Zhu, Zhihui Li, C. Caulin, T. Wei, Jihwan Park, Heng Xu   +30 more
semanticscholar   +1 more source

Cancer in the thyroid is not always thyroid cancer

HORMONES, 2003
Most clinicians assume that a thyroid mass which appears to be malignant is most likely a tumour arising from thyroid cells. We present a case where the thyroid malignancy was associated with a degree of systemic clinical and biochemical disturbance which suggested alternative diagnoses, and in which fine-needle aspiration revealed that the patient had
Diaz-Cano, Salvador J., A B Grossman, K E Akester, N Somasundaram   +3 more
openaire   +3 more sources